Pearl Therapeutics appoints new president and CEO
Pearl Therapeutics has named Chuck Bramlage president and chief executive officer. In addition, Mr. Bramlage will join the company's board of directors.
Mr. Bramlage previously held several executive positions at Covidien, most recently president of pharmaceutical products. Earlier, he served as president of European operations at Valeant Pharmaceuticals International and president and chief executive officer of BattellePharma, a specialty pharmaceutical company developing inhaled products.